Humoral immunity trends in a hemodialysis cohort following SARS-CoV-2 mRNA booster: A cohort study
Description
CONCLUSIONS: A third dose of BNT162b2 restores antibody levels to high levels in dialysis patients but levels decline over time. A third dose did not necessarily prevent infection, but no patients suffered severe infection or required hospitalization
